Cargando…
SARS-CoV-2 vaccination and uveitis: Are they linked?
In 2019, the discovery of a new strain of Coronavirus, later referred to as SARS-CoV2 took the world by storm, leading to a pandemic and shutting down all global activities. Several measures were taken adequately to combat the viral havoc, including developing numerous vaccines. All the vaccines cur...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420081/ https://www.ncbi.nlm.nih.gov/pubmed/36060437 http://dx.doi.org/10.1016/j.amsu.2022.104472 |
_version_ | 1784777313613774848 |
---|---|
author | Waseem, Summaiyya Ahmed, Syed Hassan Fatima, Sharmeen Shaikh, Taha Gul Ahmed, Jawad |
author_facet | Waseem, Summaiyya Ahmed, Syed Hassan Fatima, Sharmeen Shaikh, Taha Gul Ahmed, Jawad |
author_sort | Waseem, Summaiyya |
collection | PubMed |
description | In 2019, the discovery of a new strain of Coronavirus, later referred to as SARS-CoV2 took the world by storm, leading to a pandemic and shutting down all global activities. Several measures were taken adequately to combat the viral havoc, including developing numerous vaccines. All the vaccines currently available for the general population went through rigorous screenings and trials to ensure maximum safety and were only approved after that. However, once they were rolled out in the markets and administered to the population, some adverse reactions were reported, one of which included uveitis. It is an ocular inflammatory condition of the uveal tract, choroid, or iris. If untreated, it can lead to severe consequences, including blindness. It is further divided into four categories based on its anatomical location. Despite the rare incidence of uveitis following COVID-19 vaccination, it may contribute to vaccine hesitancy; hence addressing and digging into the pathophysiological cause is crucial. This study evaluates all the pathophysiological and demographical links between COVID-19 vaccination and uveitis, suggesting appropriate management plans. |
format | Online Article Text |
id | pubmed-9420081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94200812022-08-30 SARS-CoV-2 vaccination and uveitis: Are they linked? Waseem, Summaiyya Ahmed, Syed Hassan Fatima, Sharmeen Shaikh, Taha Gul Ahmed, Jawad Ann Med Surg (Lond) Review In 2019, the discovery of a new strain of Coronavirus, later referred to as SARS-CoV2 took the world by storm, leading to a pandemic and shutting down all global activities. Several measures were taken adequately to combat the viral havoc, including developing numerous vaccines. All the vaccines currently available for the general population went through rigorous screenings and trials to ensure maximum safety and were only approved after that. However, once they were rolled out in the markets and administered to the population, some adverse reactions were reported, one of which included uveitis. It is an ocular inflammatory condition of the uveal tract, choroid, or iris. If untreated, it can lead to severe consequences, including blindness. It is further divided into four categories based on its anatomical location. Despite the rare incidence of uveitis following COVID-19 vaccination, it may contribute to vaccine hesitancy; hence addressing and digging into the pathophysiological cause is crucial. This study evaluates all the pathophysiological and demographical links between COVID-19 vaccination and uveitis, suggesting appropriate management plans. Elsevier 2022-08-28 /pmc/articles/PMC9420081/ /pubmed/36060437 http://dx.doi.org/10.1016/j.amsu.2022.104472 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Waseem, Summaiyya Ahmed, Syed Hassan Fatima, Sharmeen Shaikh, Taha Gul Ahmed, Jawad SARS-CoV-2 vaccination and uveitis: Are they linked? |
title | SARS-CoV-2 vaccination and uveitis: Are they linked? |
title_full | SARS-CoV-2 vaccination and uveitis: Are they linked? |
title_fullStr | SARS-CoV-2 vaccination and uveitis: Are they linked? |
title_full_unstemmed | SARS-CoV-2 vaccination and uveitis: Are they linked? |
title_short | SARS-CoV-2 vaccination and uveitis: Are they linked? |
title_sort | sars-cov-2 vaccination and uveitis: are they linked? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420081/ https://www.ncbi.nlm.nih.gov/pubmed/36060437 http://dx.doi.org/10.1016/j.amsu.2022.104472 |
work_keys_str_mv | AT waseemsummaiyya sarscov2vaccinationanduveitisaretheylinked AT ahmedsyedhassan sarscov2vaccinationanduveitisaretheylinked AT fatimasharmeen sarscov2vaccinationanduveitisaretheylinked AT shaikhtahagul sarscov2vaccinationanduveitisaretheylinked AT ahmedjawad sarscov2vaccinationanduveitisaretheylinked |